GENRX ROXITHROMYCIN roxithromycin 300 mg film coated tablets blister pack

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

roxithromycin, Quantity: 300 mg

Pieejams no:

Arrotex Pharmaceuticals Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

Roxithromycin

Zāļu forma:

Tablet, film coated

Kompozīcija:

Excipient Ingredients: propylene glycol; povidone; colloidal anhydrous silica; hypromellose; titanium dioxide; sodium starch glycollate type B; sodium starch glycollate type A; maize starch; purified talc; hyprolose; glucose; magnesium stearate; poloxamer

Ievadīšanas:

Oral

Vienības iepakojumā:

5 tablets

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

Adults: Roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections caused by or likely to be caused by susceptible microorganisms: Upper respiratory tract infection: acute pharyngitis, tonsillitis and sinusitis. Lower respiratory tract infection: acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia. Skin and skin structure infections. Nongonococcal urethritis. Appropriate culture and sensitivity tests should be performed when necessary to determine organism susceptibility and thus treatment suitability. Therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.

Produktu pārskats:

Visual Identification: White to off-white, round, convex film coated tablets.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Autorizācija statuss:

Registered

Autorizācija datums:

2008-04-10